Cargando…

Recent developments in biomarkers in Parkinson disease

PURPOSE OF REVIEW: Parkinson disease is the second most common neurodegenerative disease after Alzheimer disease, and current demographic trends indicate a life-time risk approaching 4% and predict a doubling of prevalence by 2030. Strategies are being developed to apply recent advances in our under...

Descripción completa

Detalles Bibliográficos
Autor principal: Schapira, Anthony H.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196782/
https://www.ncbi.nlm.nih.gov/pubmed/23823465
http://dx.doi.org/10.1097/WCO.0b013e3283633741